Cargando…
Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma
Antiproliferation and proapoptosis are two major molecular mechanisms of action of drugs used for the treatment of multiple myeloma. Proteasome inhibitors, such as bortezomib (PS-341), and immunomodulatory drugs (IMiDs), such as lenalidomide, are the two drug types approved for the treatment of myel...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936587/ https://www.ncbi.nlm.nih.gov/pubmed/35321428 http://dx.doi.org/10.3389/fonc.2022.861709 |